Assessment of Thrombin Generation: Useful or Hype?

被引:34
作者
Adams, Murray [1 ]
机构
[1] Univ Tasmania, Sch Human Life Sci, Launceston, Tas 7250, Australia
关键词
Thrombin generation assays; hemostasis; laboratory testing; thrombosis; bleeding; PLATELET-RICH PLASMA; PARTIAL THROMBOPLASTIN TIME; TISSUE FACTOR PATHWAY; ACTIVATED PROTEIN-C; VENOUS THROMBOEMBOLISM; IN-VITRO; LUPUS ANTICOAGULANTS; BLOOD-COAGULATION; HEMOPHILIA-A; WHOLE-BLOOD;
D O I
10.1055/s-0029-1214153
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Thrombin plays an important role in hemostasis through its multiple functions across blood coagulation, platelet activation, and fibrinolysis. The measurement of thrombin generation is therefore Viewed as a potentially useful test that could be applied to the screening, monitoring, and/or diagnosis of hemostatic abnormalities. Indeed, advances in thrombin generation assays have created significant interest and debate as to whether they, may provide a more physiologically relevant testing system than do traditional coagulation tests. A variety of thrombin generation assays, including commercially available systems, have been investigated for their correlation with hypocoagulable and hyperpcoagulable states. Although there is an extensive body of literature that has investigated the application of thrombin generation assays, some limitations remain. These include poor standardization of reagents and methods and a lack of large prospective Studies that demonstrate clear relationships between thrombin generation with bleeding and thrombosis phenotypes, as well as with monitoring anticoagulation. Whether thrombin generation assays become more "Useful" than "hype" will require well-designed, large, prospective Multicenter trials using standardized methods.
引用
收藏
页码:104 / 110
页数:7
相关论文
共 52 条
[1]   Fixed dosage of low-molecular-weight heparins causes large individual variation in coagulability, only partly correlated to body weight [J].
Al Dieri, R ;
Alban, S ;
Bégun, S ;
Hemker, HC .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (01) :83-89
[2]   Thrombin generation for the control of heparin treatment, comparison with the activated partial thromboplastin time [J].
Al Dieri, R ;
Alban, S ;
Béguin, S ;
Hemker, HC .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2004, 2 (08) :1395-1401
[3]   The thrombogram in rare inherited coagulation disorders:: Its relation to clinical bleeding [J].
Al Dieri, R ;
Peyvandi, F ;
Santagostino, E ;
Giansily, M ;
Mannucci, PM ;
Schved, JF ;
Béguin, S ;
Hemker, HC .
THROMBOSIS AND HAEMOSTASIS, 2002, 88 (04) :576-582
[4]   The measurement and application of thrombin generation [J].
Baglin, T .
BRITISH JOURNAL OF HAEMATOLOGY, 2005, 130 (05) :653-661
[5]   Fibrin polymerization is crucial for thrombin generation in platelet-rich plasma in a VWF-GPIb-dependent process, defective in Bernard-Soulier syndrome [J].
Béguin, S ;
Keularts, I ;
Al Dieri, R ;
Bellucci, S ;
Caen, J ;
Hemker, HC .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2004, 2 (01) :170-176
[6]   Fibrin-dependent platelet procoagulant activity requires GPIb receptors and von Willebrand factor [J].
Béguin, S ;
Kumar, R ;
Keularts, I ;
Seligsohn, U ;
Coller, BS ;
Hemker, HC .
BLOOD, 1999, 93 (02) :564-570
[7]   Thrombin generation and phenotypic correlation in haemophilia A [J].
Beltrán-Miranda, CP ;
Khan, A ;
Jaloma-Cruz, AR ;
Laffan, MA .
HAEMOPHILIA, 2005, 11 (04) :326-334
[8]   Standardization and Clinical Utility of Thrombin-Generation Assays [J].
Berntorp, Erik ;
Salvagno, Gian Luca .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2008, 34 (07) :670-682
[9]   High rate of unprovoked recurrent venous thrombosis is associated with high thrombin-generating potential in a prospective cohort study [J].
Besser, M. ;
Baglin, C. ;
Luddington, R. ;
Vlieg, A. van Hylckama ;
Baglin, T. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2008, 6 (10) :1720-1725
[10]   Endogenous thrombin potential (ETP) in plasma from patients with AMI during antithrombotic treatment [J].
Brodin, E. ;
Seljeflot, I. ;
Arnesen, H. ;
Hurlen, M. ;
Appelbom, H. ;
Hansen, J. B. .
THROMBOSIS RESEARCH, 2009, 123 (04) :573-579